Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil dose comparison for painless endoscopy
ChiCTR2400083522Phase 4Not yet recruiting
- Sponsor
- Affiliated Suzhou Hospital of Nanjing Medical University
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of alfentanil in None (3 arms), sponsored by Affiliated Suzhou Hospital of Nanjing Medical University. Primary endpoints: SpO2 and respiratory rate. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
alfentanil
Beyond the preview
Go deeper on ChiCTR2400083522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083522.